|
| Status |
Public on Nov 05, 2010 |
| Title |
Prostate cancer primary tumor PR43 |
| Sample type |
RNA |
| |
|
| Source name |
Human prostate cancer
|
| Organism |
Homo sapiens |
| Characteristics |
tissue: Prostate cancer primary tumor
recurrence status: Non-Recurrent
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNeasy kit
|
| Label |
biotin
|
| Label protocol |
Biotinylated cRNA was prepared according to standard Affymetrix protocols
|
| |
|
| Hybridization protocol |
Following fragmentation, cRNA was hybridized to one U133A Affymetrix GeneChip.
|
| Scan protocol |
GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.
|
| Description |
PR43
Prostate cancer primary tumor
|
| Data processing |
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.
|
| |
|
| Submission date |
Nov 04, 2010 |
| Last update date |
Nov 04, 2010 |
| Contact name |
Steve Goodison |
| Organization name |
M. D. Anderson Cancer Center Orlando
|
| Department |
Cancer Research Institute
|
| Street address |
6900 Lake Nona Blvd
|
| City |
Orlando |
| ZIP/Postal code |
32827 |
| Country |
USA |
| |
|
| Platform ID |
GPL96 |
| Series (1) |
| GSE25136 |
Optimizing molecular signatures for prostate cancer recurrence |
|
